These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31487743)

  • 41. Establishment of an efficient multiplex real-time PCR assay for human papillomavirus genotyping in cervical cytology specimens: comparison with hybrid capture II.
    Lee JH; Lee NW; Hong SW; Nam YS; Choi JW; Kim YS
    Cytopathology; 2011 Aug; 22(4):261-8. PubMed ID: 20636403
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers.
    Schmitt M; Dondog B; Waterboer T; Pawlita M
    J Clin Microbiol; 2008 Mar; 46(3):1050-9. PubMed ID: 18199790
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparing triage algorithms using HPV DNA genotyping, HPV E7 mRNA detection and cytology in high-risk HPV DNA-positive women.
    Luttmer R; Berkhof J; Dijkstra MG; van Kemenade FJ; Snijders PJ; Heideman DA; Meijer CJ
    J Clin Virol; 2015 Jun; 67():59-66. PubMed ID: 25959161
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alinity m HR HPV Assay Fulfills Criteria for Human Papillomavirus Test Requirements in Cervical Cancer Screening Settings.
    Oštrbenk Valenčak A; Šterbenc A; Seme K; Poljak M
    J Clin Microbiol; 2019 Dec; 58(1):. PubMed ID: 31666369
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types.
    Gheit T; Landi S; Gemignani F; Snijders PJ; Vaccarella S; Franceschi S; Canzian F; Tommasino M
    J Clin Microbiol; 2006 Jun; 44(6):2025-31. PubMed ID: 16757593
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The development and clinical application of papillomavirus genotyping by HPV DNA suspension array the development and clinical application of papillomavirus genotyping by HPV DNA suspension array].
    Zhang S; Xing JM; Huang GY; Wu XY; Wei XF; Pan M; Min LP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):498-500. PubMed ID: 19544658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HPV genotype-specific concordance between EuroArray HPV, Anyplex II HPV28 and Linear Array HPV Genotyping test in Australian cervical samples.
    Cornall AM; Poljak M; Garland SM; Phillips S; Machalek DA; Tan JH; Quinn MA; Tabrizi SN
    Papillomavirus Res; 2017 Dec; 4():79-84. PubMed ID: 29179874
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human papillomavirus genotyping by Linear Array and Next-Generation Sequencing in cervical samples from Western Mexico.
    Flores-Miramontes MG; Torres-Reyes LA; Alvarado-Ruíz L; Romero-Martínez SA; Ramírez-Rodríguez V; Balderas-Peña LM; Vallejo-Ruíz V; Piña-Sánchez P; Cortés-Gutiérrez EI; Jave-Suárez LF; Aguilar-Lemarroy A
    Virol J; 2015 Oct; 12():161. PubMed ID: 26444975
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Performance evaluation of Anyplex™II HPV28 detection kit in a routine diagnostic setting: comparison with the HPV Sign® Genotyping Test.
    Marcuccilli F; Farchi F; Mirandola W; Ciccozzi M; Paba P; Bonanno E; Perno CF; Ciotti M
    J Virol Methods; 2015 Jun; 217():8-13. PubMed ID: 25724435
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of multiplex PCR capillary electrophoresis assay and PCR-reverse dot blot assay for human papillomavirus DNA genotyping detection in cervical cancer tissue specimens.
    Qin L; Li D; Wang Z; Lan J; Han C; Mei J; Geng J
    Front Public Health; 2024; 12():1421774. PubMed ID: 39100946
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of three human papillomavirus DNA detection methods: Next generation sequencing, multiplex-PCR and nested-PCR followed by Sanger based sequencing.
    da Fonseca AJ; Galvão RS; Miranda AE; Ferreira LC; Chen Z
    J Med Virol; 2016 May; 88(5):888-94. PubMed ID: 26496186
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The development and clinical application of papillomavirus genotyping by DNA chip].
    Yang G; Liang CH; Cui JH; Chen S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Jan; 27(1):47-9. PubMed ID: 16737573
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Validation of a Human Papillomavirus (HPV) DNA Cervical Screening Test That Provides Expanded HPV Typing.
    Demarco M; Carter-Pokras O; Hyun N; Castle PE; He X; Dallal CM; Chen J; Gage JC; Befano B; Fetterman B; Lorey T; Poitras N; Raine-Bennett TR; Wentzensen N; Schiffman M
    J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29491018
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical validation of Anyplex™ II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening.
    Hesselink AT; Sahli R; Berkhof J; Snijders PJ; van der Salm ML; Agard D; Bleeker MC; Heideman DA
    J Clin Virol; 2016 Mar; 76():36-9. PubMed ID: 26809131
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Head-to-head comparison of genotyping of human papillomavirus by GP5+/6+-PCR-based reverse dot blot hybridization assay and SPF10-PCR-based line probe assay.
    Yin J; Peng S; Li X; Zhang C; Hu F; Chen W; Qiao Y
    J Med Virol; 2023 Feb; 95(2):e28435. PubMed ID: 36571268
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the performance of different HPV genotyping methods for detecting genital HPV types.
    Klug SJ; Molijn A; Schopp B; Holz B; Iftner A; Quint W; J F Snijders P; Petry KU; Krüger Kjaer S; Munk C; Iftner T
    J Med Virol; 2008 Jul; 80(7):1264-74. PubMed ID: 18461626
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer.
    Lagheden C; Eklund C; Lamin H; Kleppe SN; Lei J; Elfström KM; Sundström K; Andrae B; Sparén P; Dillner J
    Br J Cancer; 2018 May; 118(10):1377-1381. PubMed ID: 29559733
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of analytical and clinical performances of the digene HC2 HPV DNA assay and the INNO-LiPA HPV genotyping assay for detecting high-risk HPV infection and cervical neoplasia among HIV-positive African women.
    Ngou J; Gilham C; Omar T; Goumbri-Lompo O; Doutre S; Michelow P; Kelly H; Didelot MN; Chikandiwa A; Sawadogo B; Delany-Moretlwe S; Meda N; Costes V; Mayaud P; Segondy M
    J Acquir Immune Defic Syndr; 2015 Feb; 68(2):162-8. PubMed ID: 25394189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development and validation of a multiplex reverse transcript real-time PCR for E6/E7 mRNA detection of high-risk human papillomavirus.
    Pan C; Zhou J; Lyu J; Ren X
    J Med Microbiol; 2018 Oct; 67(10):1509-1514. PubMed ID: 30124401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.